New fentanyl analogs have recently emerged as new psychoactive substances and have
caused numerous fatalities worldwide. To determine if the new analogs follow the same …

Introduction. Novel synthetic 'designer'drugs with stimulant, ecstasy-like (entactogenic)
and/or hallucinogenic properties have become increasingly popular among recreational …

Fatal intoxications due to accidental or voluntary intake of synthetic opioids represent an
actual emerging issue. We report a case where we have analyzed furanyl fentanyl and its …

The term “new psychoactive substances”(NPS) can be defined as individual drugs in pure
form or in complex preparations that are not scheduled under the Single Convention on …

In recent years, there has been a substantial increase in opioid use and abuse, and in
opioid-related fatal overdoses. The increase in opioid use has resulted at least in part from …

Since 1979, the potent narcotic analgesic fentanyl and its analogs have been synthesized in
clandestine laboratories and sold as heroin substitutes. At least 112 overdose deaths have …

The prevalence of new psychoactive substances (NPS) on the illicit drug market continues to
grow, with new analogs being routinely synthesized. Routes of administration for these …

The unprecedented proliferation of novel psychoactive substances (NPS) in the illicit drug
market has been a public health concern since their emergence in the 2000s. Their …

Abstract AH-7921 (3, 4-dichloro-N-[(1-dimethylamino) cyclohexylmethyl] benzamide) is a
designer opioid with∼ 80% of morphine's µ-agonist activity. Over a 6-month period, we …

Background The last decade has seen a rapid and continuous growth in the availability and
use of novel psychoactive substances (NPS) across the world. Although various products …